We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Syndrome Arrays from Randox offer Simultaneous Patient Profiling with Randox Metabolic Syndrome Arrays


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Syndrome Arrays from Randox offer Simultaneous Patient Profiling with Randox Metabolic Syndrome Arrays"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The Metabolic determination of analytes associated with Metabolic Syndrome and related disorders for improved patient profiling.

Metabolic Syndrome Array I includes these analytes; C-peptide, Ferritin, IL-1a, IL- 6, Insulin, Leptin, Plasminogen Activator Inhibitor-I, Resistin and Tumour Necrosis Factor a. Metabolic Syndrome Array II includes; Adiponectin, CRP and Cystatin C. Utilizing multiplexing Biochip technology, these arrays can provide cost and time savings as multiple assays can be run on one sample, according to Randox.

The Metabolic Syndrome Arrays are suitable for use on plasma and serum, using only 100 µl of sample to measure all analytes on each array. Randox also offer a complete range of multi- analyte controls and calibrators to ensure reliable results.
Advertisement